首页|尼莫地平联合丁苯酞氯化钠注射液治疗脑小血管病合并认知功能障碍的效果及对神经因子水平的影响

尼莫地平联合丁苯酞氯化钠注射液治疗脑小血管病合并认知功能障碍的效果及对神经因子水平的影响

扫码查看
目的 分析尼莫地平联合丁苯酞氯化钠注射液治疗脑小血管病合并认知功能障碍的效果及对神经因子水平的影响。方法 选择2020年1月至2022年4月收治的106例脑小血管病合并认知功能障碍患者为研究对象,以随机数字表法将其分为对照组、观察组,每组53例。对照组接受丁苯酞氯化钠注射液治疗,观察组在对照组基础上加用尼莫地平治疗。比较两组的治疗效果。结果 治疗后,观察组的大脑中动脉(MCA)、大脑前动脉(ACA)、大脑后动脉(PCA)血流速度高于对照组(P<0。05)。治疗后,观察组的神经元特异性烯醇化酶(NSE)、髓鞘碱性蛋白(MBP)水平低于对照组,神经生长因子(NGF)、脑源性神经营养因子(BDNF)水平高于对照组(P<0。05)。治疗后,观察组的简易智力状态检查量表(MMSE)、改良长谷川痴呆量表(HDS-R)、蒙特利尔认知评估量表(MoCA)评分高于对照组(P<0。05)。结论 尼莫地平联合丁苯酞氯化钠注射液治疗脑小血管病合并认知功能障碍可改善患者的脑血流状态及神经因子水平,促进认知功能恢复,值得推广与应用。
Effect of nimodipine combined with butylphthalide and sodium chloride injection in the treatment of cerebral small vessel disease complicated with cognitive dysfunction and its influences on the levels of nerve factors
Objective To analyze the effect of nimodipine combined with butylphthalide and sodium chloride injection in the treatment of cerebral small vessel disease complicated with cognitive dysfunction and its influences on the levels of nerve factors.Methods A total of 106 patients with cerebral small vessel disease complicated with cognitive dysfunction admitted from January 2020 to April 2022 were selected as the research objects,and the patients were divided into control group and observation group by random number table method,with 53 cases in each group.The control group was treated with butylphthalide and sodium chloride injection,and the observation group was treated with nimodipine on the basis of the control group.The therapeutic effects of the two groups were compared.Results After treatment,the blood flow velocity of middle cerebral artery(MCA),anterior cerebral artery(ACA)and posterior cerebral artery(PCA)in the observation group were higher than those in the control group(P<0.05).After treatment,the levels of neuron specific enolase(NSE)and myelin basic protein(MBP)in the observation group were lower than those in the control group,and the levels of nerve growth factor(NGF)and brain-derived neurotrophic factor(BDNF)were higher than those in the control group(P<0.05).After treatment,the scores of Mini-Mental State Examination(MMSE),Revised Hasegawa Dementia Scale(HDS-R)and Montreal Cognitive Assessment(MoCA)in the observation group were higher than those in the control group(P<0.05).Conclusion Nimodipine combined with butylphthalide and sodium chloride injection in the treatment of cerebral small vessel disease complicated with cognitive dysfunction can improve the cerebral blood flow state and nerve factors levels of patients,and promote the recovery of cognitive function,which is worthy of promotion and application.

nimodipinebutylphthalide and sodium chloride injectioncerebral small vessel diseasecognitive dysfunctionnerve factor

李婷婷、王文娟、方永军

展开 >

咸阳市中心医院,陕西咸阳,712000

陕西中医药大学附属医院,陕西咸阳,712000

尼莫地平 丁苯酞氯化钠注射液 脑小血管病 认知功能障碍 神经因子

2020年度中国民族医药学会科研项目

2020ZY129-410401

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(5)
  • 18